Xiulin Jiang

3.4k total citations · 1 hit paper
64 papers, 2.1k citations indexed

About

Xiulin Jiang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiulin Jiang has authored 64 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 46 papers in Cancer Research and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiulin Jiang's work include RNA modifications and cancer (44 papers), Cancer-related molecular mechanisms research (38 papers) and Ferroptosis and cancer prognosis (20 papers). Xiulin Jiang is often cited by papers focused on RNA modifications and cancer (44 papers), Cancer-related molecular mechanisms research (38 papers) and Ferroptosis and cancer prognosis (20 papers). Xiulin Jiang collaborates with scholars based in China, United States and United Kingdom. Xiulin Jiang's co-authors include Lincan Duan, Yongbin Chen, Cuiping Yang, Qiuxia Xiong, Zhi Nie, Baiyang Liu, Zhixian Jin, Yixiao Yuan, Lin Tang and Qiushuo Shen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Cell Death and Differentiation.

In The Last Decade

Xiulin Jiang

53 papers receiving 2.1k citations

Hit Papers

The role of m6A modification in the biological functions ... 2021 2026 2022 2024 2021 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The role of m6A modification in the biological functions and diseases
    2021 1.4k citations Xiulin Jiang, Zhi Nie et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiulin Jiang China 14 1.9k 1.0k 264 236 175 64 2.1k
Lincan Duan China 15 1.8k 0.9× 983 0.9× 299 1.1× 241 1.0× 168 1.0× 37 2.1k
Hengyou Weng China 16 2.6k 1.4× 1.3k 1.3× 274 1.0× 108 0.5× 308 1.8× 29 2.7k
Youtao Xu China 21 1.6k 0.8× 1.4k 1.4× 249 0.9× 294 1.2× 37 0.2× 43 2.0k
Chengwu Zeng China 22 1.6k 0.8× 1.2k 1.1× 323 1.2× 133 0.6× 68 0.4× 60 2.1k
Yuting Zhan China 19 739 0.4× 490 0.5× 234 0.9× 183 0.8× 46 0.3× 63 1.1k
Guangchao Cao China 16 1.3k 0.7× 721 0.7× 235 0.9× 71 0.3× 136 0.8× 25 1.7k
Junhu Wan China 21 1.1k 0.6× 740 0.7× 167 0.6× 159 0.7× 24 0.1× 46 1.3k
Dongjian Ji China 17 848 0.4× 606 0.6× 191 0.7× 111 0.5× 37 0.2× 28 1.0k

Countries citing papers authored by Xiulin Jiang

Since Specialization
Citations

This map shows the geographic impact of Xiulin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiulin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiulin Jiang more than expected).

Fields of papers citing papers by Xiulin Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiulin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiulin Jiang. The network helps show where Xiulin Jiang may publish in the future.

Co-authorship network of co-authors of Xiulin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiulin Jiang. A scholar is included among the top collaborators of Xiulin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiulin Jiang. Xiulin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chunhong, et al.. (2025). Cellular senescence: from homeostasis to pathological implications and therapeutic strategies. Frontiers in Immunology. 16. 1534263–1534263. 4 indexed citations
2.
Chen, Xi, et al.. (2025). m6A RNA modification in tumor-associated macrophages: emerging roles in cancer immunity. Frontiers in Immunology. 16. 1693336–1693336.
3.
Li, Chunhong, Yixiao Yuan, Xiulin Jiang, & Qiang Wang. (2025). Epigenetic regulation of CD8+ T cell exhaustion: recent advances and update. Frontiers in Immunology. 16. 1700039–1700039. 2 indexed citations
4.
Wang, Qiang, Yixiao Yuan, Qiang Zhou, et al.. (2025). RNA N4‐acetylcytidine modification and its role in health and diseases. MedComm. 6(1). e70015–e70015. 7 indexed citations
5.
Wang, Qiang, Xiulin Jiang, Yixiao Yuan, & Chunhong Li. (2025). METTL16 emerges as a pivotal epitranscriptomic regulator, linking RNA modification, tumor progression, and immune modulation. Frontiers in Immunology. 16. 1706971–1706971.
6.
7.
Li, Chunhong, Xiulin Jiang, Yixiao Yuan, & Qiang Wang. (2025). METTL14 in tumor immunity: epitranscriptomic regulation and therapeutic potential. Frontiers in Immunology. 16. 1709742–1709742.
8.
Wang, Qiang, Yixiao Yuan, Jing Liu, Chunhong Li, & Xiulin Jiang. (2024). The role of mitochondria in aging, cell death, and tumor immunity. Frontiers in Immunology. 15. 1520072–1520072. 7 indexed citations
9.
Wang, Qiang, et al.. (2023). lncRNA PCBP1-AS1 mediated downregulation of ITGAL as a prognostic biomarker in lung adenocarcinoma. Aging. 15(10). 4510–4523. 6 indexed citations
10.
Ren, Wenjun, Yixiao Yuan, Yongwu Li, et al.. (2023). The function and clinical implication of YTHDF1 in the human system development and cancer. Biomarker Research. 11(1). 5–5. 33 indexed citations
11.
12.
Shen, Qiushuo, Yanfei Han, Kai Wu, et al.. (2022). MrgprF acts as a tumor suppressor in cutaneous melanoma by restraining PI3K/Akt signaling. Signal Transduction and Targeted Therapy. 7(1). 147–147. 29 indexed citations
13.
Nie, Zhi, Chenyang Wang, Ping Li, et al.. (2022). Extra Spindle Pole Bodies-Like 1 Serves as a Prognostic Biomarker and Promotes Lung Adenocarcinoma Metastasis. Frontiers in Oncology. 12. 930647–930647. 8 indexed citations
14.
Jiang, Xiulin, Lin Tang, Yixiao Yuan, et al.. (2022). NcRNA-Mediated High Expression of HMMR as a Prognostic Biomarker Correlated With Cell Proliferation and Cell Migration in Lung Adenocarcinoma. Frontiers in Oncology. 12. 846536–846536. 11 indexed citations
15.
Yuan, Yixiao, Xiulin Jiang, Lin Tang, et al.. (2022). FOXM1/lncRNA TYMSOS/miR-214-3p–Mediated High Expression of NCAPG Correlates With Poor Prognosis and Cell Proliferation in Non–Small Cell Lung Carcinoma. Frontiers in Molecular Biosciences. 8. 785767–785767. 24 indexed citations
16.
Wang, Chunyan, et al.. (2022). Long Non-Coding RNA AP000695.2 Acts as a Novel Prognostic Biomarker and Regulates the Cell Growth and Migration of Lung Adenocarcinoma. Frontiers in Molecular Biosciences. 9. 895927–895927. 5 indexed citations
17.
Jiang, Xiulin, Yulin Shi, Xi Chen, et al.. (2022). The N6-Methylandenosine-Related Gene BIRC5 as a Prognostic Biomarker Correlated With Cell Migration and Immune Cell Infiltrates in Low Grade Glioma. Frontiers in Molecular Biosciences. 9. 773662–773662. 5 indexed citations
18.
Jiang, Xiulin, Yulin Shi, Xi Chen, et al.. (2022). NCAPG as a Novel Prognostic Biomarker in Glioma. Frontiers in Oncology. 12. 831438–831438. 10 indexed citations
19.
20.
Jiang, Xiulin, Yixiao Yuan, Lin Tang, et al.. (2021). Comprehensive Pan-Cancer Analysis of the Prognostic and Immunological Roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C Axis. Frontiers in Cell and Developmental Biology. 9. 765772–765772. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lincan Duan Breakdown of academic impact, for papers by Hengyou Weng Breakdown of academic impact, for papers by Youtao Xu Breakdown of academic impact, for papers by Chengwu Zeng Breakdown of academic impact, for papers by Yuting Zhan Breakdown of academic impact, for papers by Guangchao Cao Breakdown of academic impact, for papers by Junhu Wan Breakdown of academic impact, for papers by Dongjian Ji
Rankless by CCL
2026